Development of our current understanding of bioactive lysophospholipids

Annals of the New York Academy of Sciences

Volumn 905, Issue , 2000, Pages 1-10

  Moolenaar, Wouter H ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; GROWTH FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; HORMONE; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHOLIPID; RHO FACTOR; SPHINGOSINE 1 PHOSPHATE;

ANIMAL CELL; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SHAPE; CONFERENCE PAPER; CYTOSKELETON; GAP JUNCTION; HUMAN; HUMAN CELL; MEDIATOR; NEURITE; NONHUMAN; TUMOR CELL;

ANIMALIA;

EID: 0034060152     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06532.x     Document Type: Conference Paper

References (37)

1. 1. MOOLENAAR, W.H. 1995. Lysophosphatidic acid, a multifunctional phospholipid messenger. J. Biol. Chem. 270: 12949-12952.
2. 2. MOOLENAAR, W.H. et al. 1997. Lysophosphatidic acid: G protein signalling and cellular responses. Curr. Opin. Cell Biol. 9: 168-173.
3. 3. MOOLENAAR, W.H. 1999. Bioactive lysophospholipids and their G protein-coupled receptors. Exp. Cell Res. 253: 230-238.
4. 4. CHUN, J. et al. 1999. A growing family of receptor genes for lysophosphatidic acid (LPA) and other lysophospholipids (LPs). Cell Biochem. Biophys. 30: 213-242.
5. 5. GOETZL, E.J. & S. AN. 1998. Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate. FASEB J. 12: 1589-1598.
6. 6. MOOLENAAR, W.H. et al. 1986. Growth factor-like action of phosphatidic acid. Nature 323:171-173.
7. 7. VAN CORVEN, E. et al. 1989. Lysophosphatidate-induced cell proliferation: identification and dissection of signalling pathways mediated by G proteins. Cell 59: 45-54.
8. 2+-mobilizing stimulus for fibroblasts. J. Biol. Chem. 265: 12232-12239.
9. 9. VAN DER BEND, R.L. et al. 1992. Identification of a putative membrane receptor for the bioactive phospholipid, lysophosphatidic acid. EMBO J. 11: 2495-2501.
10. 10. HECHT, J.H. et al. 1996. Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex. J. Cell Biol. 135: 1071-1083.
11. 11. JALINK, K. et al. 1993. Lysophosphatidic acid induces neuronal shape changes via a novel, receptor-mediated signaling pathway: similarity to thrombin action. Cell Growth & Differ. 4: 247-255.
12. 12. JALINK, K. et al. 1994. Inhibition of lysophosphatidate-and thrombin-induced neurite retraction and neuronal cell rounding by ADP ribosylation of the small GTP-binding protein rho. J. Cell Biol. 126: 801-810.
13. 13. LEE, M.J. et al. 1998. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-I. Science 279: 1552-1555.
14. 14. ZONDAG, G.C. et al. 1998. Sphingosine 1-phosphate signalling through the G-protein-coupled receptor Edg-1. Biochem. J. 330: 605-609.
15. 15. EICHHOLTZ, T. et al. 1993. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem. J. 291: 677-680.
16. 16. TIGYI, G. & R. MILEDI. 1992. Lysophosphatidates bound to serum albumin activate membrane currents in Xenopus oocytes and neurite retraction in PC12 pheochromacytoma cells. J. Biol. Chem. 267: 21360-21367.
17. 17. YATOMI, Y. et al. 1995. Sphingosine-1-phosphate: A platelet-activating sphingolipid released from agonist-stimulated human platelets. Blood 86: 193-202.
18. 18. POSTMA, F.R. et al. 1996. Sphingosine-1-phosphate rapidly induces Rho-dependent neurite retraction: action through a specific cell surface receptor. EMBO J. 15: 2388-2392.
19. 19. FOURCADE, O. et al. 1995. Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell 80: 919-927.
20. 2+ signaling pathways. Curr. Biol. 8: 386-392.
21. 21. XU, Y. et al. 1995. Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients. Clin. Cancer Res. 1: 1223-1232.
22. 22. WESTERMANN, A.M. et al. 1998. Malignant effusions contain lysophosphatidic acid (LPA)-like activity. Ann. Oncol. 9: 437-442.
23. 23. XU, Y. et al. 1998. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. JAMA 280: 719-723.
24. 24. SIESS, W. et al. 1999. Lysophosphatidic acid mediates the rapid activation of platelets andendothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. Proc. Natl. Acad. Sci. USA 96: 6931-6936.
25. 25. PIAZZA, G.A. et al. 1995. Lysophosphatidic acid induction of transforming growth factors alpha and beta: modulation of proliferation and differentiation in cultured human keratinocytes and mouse skin. Exp. Cell Res. 216: 51-64.
26. 26. DUBIN, A.E. et al. 1999. Lysophosphatidic acid stimulates neurotransmitter-like conductance changes that precede GABA and L-glutamate in early, presumptive cortical neuroblasts. J. Neurosci. 19: 1371-1381.
27. 27. POSTMA, F.R. et al. 1996. Serum-induced membrane depolarization in quiescent fibroblasts: activation of a chloride conductance through the G protein-coupled LPA receptor. EMBO J. 15: 63-72.
28. 28. HIROSE, M. et al. 1998. Molecular dissection of the Rho-associated protein kinase (p160ROCK)-regulated neurite remodeling in neuroblastoma N1E-115 cells. J. Cell Biol. 141: 1625-1636.
29. 29. KRANENBURG, O. et al. 1999. Activation of RhoA by lysophosphatidic acid and Gα12/13 subunits in neuronal cells: induction of neurite retraction. Mol. Biol. Cell 10: 1851-1857.
30. 30. KOZASA, T. et al. 1998. p115 RhoGEF, a GTPase activating protein for Galpha12 and Galpha13. Science 280: 2109-2111.
31. 31. SUIDAN, H.S. et al. 1997. Astrocyte spreading in response to thrombin and lysophosphatidic acid is dependent on the Rho GTPase. Glia 21: 244-252.
32. 32. RAMAKERS, G.A. & W.H. MOOLENAAR. 1998. Regulation of astrocyte morphology by RhoA and lysophosphatidic acid. Exp. Cell Res. 245: 252-262.
33. 33. RIDET, J.L. et al. 1997. Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci. 20: 570-577.
34. 34. IMAMURA, F. et al. 1993. Induction of in vitro tumor cell invasion of cellular monolayers by lysophosphatidic acid or phospholipase D. Biochem. Biophys. Res. Commun. 193: 497-503.
35. 35. YOSHIOKA, K. et al. 1998. Small GTP-binding protein Rho stimulates the actomyosin system, leading to invasion of tumor cells. J. Biol. Chem. 273: 5146-5154.
36. 36. STAM, J.C. et al. 1998. Invasion of T-lymphoma cells: cooperation between Rho family GTPases and lysophospholipid receptor signaling. EMBO J. 17: 4066-4074.
37. 37. POSTMA, F.R. et al. 1998. Acute loss of cell-cell communication caused by G protein-coupled receptors: a critical role for c-Src. J. Cell Biol. 140: 1199-1209.